In this issue:
Ocrelizumab ‘wearing-off’
Intrathecal MSC-NP therapy in progressive MS
Anti-CD20 monoclonal antibodies in pregnancy/lactation
EBV in MS pathogenesis
Head trauma, genetic susceptibility & risk of MS
Relapses with stable MRI
Clinical relapses & disease outcomes in patients >50 years
VOC & cognitive reserve in MS
RCT emulation using observational, real-world data
EMPhASIS: dose-response of vidofludimus calcium in RRMS
Please login below to download this issue (PDF)